Comprehensive Expression Profiling and Molecular Basis of CDC28 Protein Kinase Regulatory Subunit 2 in Cervical Cancer.
Journal
International journal of genomics
ISSN: 2314-4378
Titre abrégé: Int J Genomics
Pays: United States
ID NLM: 101605206
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
03
2022
accepted:
27
06
2022
entrez:
8
8
2022
pubmed:
9
8
2022
medline:
9
8
2022
Statut:
epublish
Résumé
More and more evidence suggests the oncogenic function of overexpressed CDC28 protein kinase regulatory subunit 2 (CKS2) in various human cancers. However,
Identifiants
pubmed: 35935749
doi: 10.1155/2022/6084549
pmc: PMC9352497
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6084549Informations de copyright
Copyright © 2022 Li Qin et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Oncol Lett. 2019 Sep;18(3):2845-2852
pubmed: 31452763
Med Sci Monit. 2022 Apr 16;28:e934799
pubmed: 35428744
Cancers (Basel). 2020 Oct 09;12(10):
pubmed: 33050319
Cancer Med. 2021 Aug;10(16):5574-5588
pubmed: 34240817
Med Sci Monit. 2021 Mar 05;27:e928523
pubmed: 33667214
J Cancer. 2020 Sep 25;11(22):6704-6715
pubmed: 33046993
Front Oncol. 2021 Apr 09;11:639980
pubmed: 33898314
Gynecol Oncol. 2022 Jul;166(1):108-116
pubmed: 35490034
Mol Cancer Res. 2021 Oct;19(10):1712-1726
pubmed: 34183451
BMC Public Health. 2021 Jun 5;21(1):1071
pubmed: 34090372
Front Cell Dev Biol. 2020 Jun 12;8:474
pubmed: 32596243
Neoplasia. 2019 Apr;21(4):353-362
pubmed: 30856376
J Cancer. 2021 Jun 11;12(16):4891-4900
pubmed: 34234859
Mol Cell Biol. 2021 Jul 23;41(8):e0005921
pubmed: 34031216
Neural Regen Res. 2019 Jun;14(6):1099-1104
pubmed: 30762025
PeerJ. 2020 Oct 07;8:e10126
pubmed: 33083148
Int J Oncol. 2021 Jul;59(1):
pubmed: 34132354
PeerJ. 2020 Dec 08;8:e10458
pubmed: 33354424
Mol Cell Biol. 2008 Sep;28(18):5698-709
pubmed: 18625720
Clin Transl Oncol. 2011 Jul;13(7):431-3
pubmed: 21775268
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cell Physiol Biochem. 2018;50(5):1964-1987
pubmed: 30396166
Asian Pac J Cancer Prev. 2021 Jun 01;22(6):1713-1720
pubmed: 34181325
Dis Markers. 2019 Oct 22;2019:8964015
pubmed: 31781310
Molecules. 2020 Apr 23;25(8):
pubmed: 32340124
Int J Nanomedicine. 2021 Jun 15;16:4087-4104
pubmed: 34163161
Front Oncol. 2021 Jun 07;11:655302
pubmed: 34164340
BMC Genomics. 2006 Oct 20;7:268
pubmed: 17054779
J Womens Health (Larchmt). 2021 Jul;30(7):972-978
pubmed: 33826419
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1273-1280
pubmed: 30963795
Am J Transl Res. 2021 Jun 15;13(6):6654-6661
pubmed: 34306409
BMC Cancer. 2021 Apr 16;21(1):421
pubmed: 33863313
Biomed Res Int. 2021 Mar 19;2021:8810074
pubmed: 33829064
Int J Clin Oncol. 2021 Oct;26(10):1968-1976
pubmed: 34165659
Biochem Biophys Res Commun. 2017 Jun 3;487(3):625-632
pubmed: 28435071
Onco Targets Ther. 2017 Jul 20;10:3667-3683
pubmed: 28790856
J Oral Pathol Med. 2021 Feb;50(2):175-182
pubmed: 33107644
Int J Clin Exp Pathol. 2019 May 01;12(5):1518-1528
pubmed: 31933969
Endocr Metab Immune Disord Drug Targets. 2022;22(5):510-517
pubmed: 34161216
Hereditas. 2020 Oct 14;157(1):41
pubmed: 33054858